Extracellular signal-regulated kinase 2 mediates the expression of granulocyte colony-stimulating factor in invasive cancer cells

Oncology Reports

Volumn 30, Issue 1, 2013, Pages 419-424

  Lee, Chia Huei ^a   Lin, Szu Han ^b   Chang, Shwu Fen ^c   Chang, Po Yuan ^d   Yang, Zhi Ping ^a   Lu, Shao Chun ^b  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cancer; ERK2; G CSF; MAPK; MEK

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; GRANULOCYTE COLONY STIMULATING FACTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SHORT HAIRPIN RNA; TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL LEVEL; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MOUTH CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION;

ADENOCARCINOMA; BREAST NEOPLASMS; BUTADIENES; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LUNG NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASMS; NITRILES; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84878203741     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2463     Document Type: Article

References (25)

1. Welte K, Platzer E, Lu L, Gabrilove JL, Levi E, Mertelsmann R and Moore MA: Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc Natl Acad Sci USA 82: 1526-1530, 1985. (Pubitemid 15120576)
2. Nicola NA and Metcalf D: Binding of the differentiation-inducer, granulocyte-colony-stimulating factor, to responsive but not unresponsive leukemic cell lines. Proc Natl Acad Sci USA 81: 3765-3769, 1984. (Pubitemid 14087799)
3. Demetri GD and Griffin JD: Granulocyte colony-stimulating factor and its receptor. Blood 78: 2791-2808, 1991.
4. Kawakami M, Tsutsumi H, Kumakawa T, Abe H, Hirai M, Kurosawa S, et al: Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood 76: 1962-1964, 1990.
5. Dale DC: Colony-stimulating factors for the management of neutropenia in cancer patients. Drugs 62 (Suppl 1): 1-15, 2002.
6. Carl W and Havens J: The cancer patient with severe mucositis. Curr Rev Pain 4: 197-202, 2000.
7. Obermueller E, Vosseler S, Fusenig NE and Mueller MM: Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells. Cancer Res 64: 7801-7812, 2004. (Pubitemid 39446913)
8. Mueller MM, Peter W, Mappes M, Huelsen A, Steinbauer H, Boukamp P, et al: Tumor progression of skin carcinoma cells in vivo promoted by clonal selection, mutagenesis, and autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. Am J Pathol 159: 1567-1579, 2001. (Pubitemid 32947984)
9. Braun B, Lange M, Oeckler R and Mueller MM: Expression of G-CSF and GM-CSF in human meningiomas correlates with increased tumor proliferation and vascularization. J Neurooncol 68: 131-140, 2004. (Pubitemid 39137337)
10. Chu YW, Yang PC, Yang SC, Shyu YC, Hendrix MJ, Wu R, et al: Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am J Respir Cell Mol Biol 17: 353-360, 1997. (Pubitemid 127500840)
11. Egberts JH, Cloosters V, Noack A, Schniewind B, Thon L, Klose S, et al: Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis. Cancer Res 68: 1443-1450, 2008. (Pubitemid 351346852)
12. Kulbe H, Thompson R, Wilson JL, Robinson S, Hagemann T, Fatah R, et al: The inflammatory cytokine tumor necrosis factor-α generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res 67: 585-592, 2007. (Pubitemid 46192196)
13. Stathopoulos GT, Kollintza A, Moschos C, Psallidas I, Sherrill TP, Pitsinos EN, et al: Tumor necrosis factor-α promotes malignant pleural effusion. Cancer Res 67: 9825-9834, 2007. (Pubitemid 47621230)
14. Koeffler HP, Gasson J, Ranyard J, Souza L, Shepard M and Munker R: Recombinant human TNF alpha stimulates production of granulocyte colony-stimulating factor. Blood 70: 55-59, 1987. (Pubitemid 17111241)
15. Seger R, Ahn NG, Posada J, Munar ES, Jensen AM, Cooper JA, et al: Purification and characterization of mitogen-activated protein kinase activator(s) from epidermal growth factor-stimulated A431 cells. J Biol Chem 267: 14373-14381, 1992.
16. Hoshino R, Chatani Y, Yamori T, Tsuruo T, Oka H, Yoshida O, et al: Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors. Oncogene 18: 813-822, 1999. (Pubitemid 29080340)
17. Vantaggiato C, Formentini I, Bondanza A, Bonini C, Naldini L and Brambilla R: ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially. J Biol 5: 14, 2006.
18. Yao Y, Li W, Wu J, Germann UA, Su MS, Kuida K and Boucher DM: Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation. Proc Natl Acad Sci USA 100: 12759-12764, 2003. (Pubitemid 37339972)
19. Carlson SM, Chouinard CR, Labadorf A, Lam CJ, Schmelzle K, Fraenkel E and White FM: Large-scale discovery of ERK2 substrates identifies ERK-mediated transcriptional regulation by ETV3. Sci Signal 4: rs11, 2011.
20. Chou YY and Lu SC: Inhibition by rapamycin of the lipoteichoic acid-induced granulocyte-colony stimulating factor expression in mouse macrophages. Arch Biochem Biophys 508: 110-119, 2011.
21. Chou YY, Gao JI, Chang SF, Chang PY and Lu SC: Rapamycin inhibits lipopolysaccharide induction of granulocyte-colony stimulating factor and inducible nitric oxide synthase expression in macrophages by reducing the levels of octamer-binding factor-2. FEBS J 278: 85-96, 2011.
22. Armstrong DA, Phelps LN and Vincenti MP: CCAAT enhancer binding protein-â regulates matrix metalloproteinase-1 expression in interleukin-1β-stimulated A549 lung carcinoma cells. Mol Cancer Res 7: 1517-1524, 2009.
23. Coussens LM and Werb Z: Inflammation and cancer. Nature 420: 860-867, 2002. (Pubitemid 36019639)
24. Karin M: Nuclear factor-κB in cancer development and progression. Nature 441: 431-436, 2006.
25. Huber MA, Azoitei N, Baumann B, Grünert S, Sommer A, Pehamberger H, et al: NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 114: 569-581, 2004. (Pubitemid 39572107)